Pentoxifylline in Diabetic Kidney Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 2376 participants.
Also called NCT03625648
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,376 participants
- Registry
-
NCT03625648
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT03625648. Randomized; quadruple masking; primary purpose treatment. Start 2019-11-18 (actual); primary completion 2028-01-03 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pentoxifylline in Diabetic Kidney Disease
- Acronym
- VA PTXRx
- Condition
- Diabetic Kidney Disease
- Intervention (Drug)
- Pentoxifylline
- Intervention (Drug)
- Placebo
- Lead sponsor
- VA Office of Research and Development
Record details
- Record id
cardio:ct-nct03625648- Content hash
fa6e8c0225665aac6c6329a937f9933d10f187cedd4f3b8aebf8302c69d28b63